top of page

Tirzepatide

Dual GIP/GLP-1 receptor agonist 

One of the most potent weight loss solution. Patients using tirzepatide are experiencing a weight loss of up to 22.5%, which is more than twice as effective as other weight loss medications available in the market. Tirzepide operates on GLP-1 receptors, similar to semaglutide, and also targets an additional receptor called GIP, making it a unique "twincretin" that has demonstrated superior weight loss and glucose control. Book a free consultation with us today to learn more about this medication!

Tirzepatide graph.png

Get Started Today

Contact Us
bottom of page